Product Categories
| Country: | China |
|---|---|
| Tel: | 13720134139 086-15871494362 |
| Mobile: | +8613720134139 |
| E-mail: | orders@jknbiochem.com |
| QQ: | 3655618288 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Tanezumab | 880266-57-9 | Details |
| Tenatumomab | 1412891-40-7 | Details |
| Research Grade Camidanlumab | 921618-45-3 | Details |
| Efungumab | 762260-74-2 | Details |
| Stamulumab | 705287-60-1 | Details |
| Research Grade Lerdelimumab | 285985-06-0 | Details |
| Conatumumab | 896731-82-1 | Details |
| Regavirumab | 153101-26-9 | Details |
| Zanolimumab | 652153-01-0 | Details |
| Research Grade J695 | Details |
| Research Grade Otilimab | 1638332-55-4 | Details |
| Zalutumumab | 667901-13-5 | Details |
| Racotumomab | 946832-34-4 | Details |
| Lexatumumab | 845816-02-6 | Details |
| Nebacumab | 138661-01-5 | Details |
| Catumaxomab | 509077-98-9 | Details |
| Research Grade HuCC49 | 823788-82-5 | Details |
| Panitumumab | 339177-26-3 | Details |
| Gantenerumab | 1043556-46-2 | Details |
| Fresolimumab | 948564-73-6 | Details |
| Mapatumumab | 658052-09-6 | Details |
| ofatumumab | 679818-59-8 | Details |
| Metelimumab | 272780-74-2 | Details |
| Ipilimumab | 477202-00-9 | Details |
| Ertumaxomab | 509077-99-0 | Details |
| Research Grade Golimumab | 476181-74-5 | Details |
| Acadesine | C9H14N4O5 | 2627-69-2 | Details |
| Maribavir | C15H19Cl2N3O4 | 176161-24-3 | Details |
| GW501516 | C21H18F3NO3S2 | 317318-70-0 | Details |
| Andarine | C19H18F3N3O6 | 401900-40-1 | Details |
| YK11 | C25H34O6 | 431579-34-9 | Details |
| MK-677 | C28H40N4O8S2 | 159752-10-0 | Details |
| ocrelizumab | C19H16N2O5 | 637334-45-3 | Details |
| Ganitumab | 905703-97-1 | Details |
| Briakinumab | 339308-60-0 | Details |
| Tralokinumab | 1044515-88-9 | Details |
| Adecatumumab | 503605-66-1 | Details |
| Tuvirumab | 138660-97-6 | Details |
| Ustekinumab | 815610-63-0 | Details |
| Research Grade Priliximab | 147191-91-1 | Details |
| Bertilimumab | 375348-49-5 | Details |
| Lumiliximab | 357613-86-6 | Details |
| Research Grade Clenoliximab | 182912-58-9 | Details |
| Keliximab | 174722-30-6 | Details |
| Galiximab | 357613-77-5 | Details |
| Infliximab | 170277-31-3 | Details |
| Cetuximab | C107H179N35O36S7 | 205923-56-4 | Details |
| LGD-3303 | C16H14ClF3N2O | 917891-35-1 | Details |
| SR9009 | C20H24ClN3O4S | 1379686-30-2 | Details |
| RAD-140 | C20H16ClN5O2 | 1182367-47-0 | Details |
| LGD4033 | C14H12F6N2O | 1165910-22-4 | Details |
| Ostarine | C19H14F3N3O3 | 841205-47-8 | Details |
| Tigatuzumab | 918127-53-4 | Details |
| Citatuzumab Bogatox | 945228-49-9 | Details |
| Otelixizumab | 881191-44-2 | Details |
| Dacetuzumab | 880486-59-9 | Details |
| Alacizumab | 934216-54-3 | Details |
| Anrukinzumab | 910649-32-0 | Details |
| Obinutuzumab | 949142-50-1 | Details |
| Etaracizumab | 892553-42-3 | Details |
| Oportuzumab Monatox | 945228-48-8 | Details |
| Canakinumab | 914613-48-2 | Details |
| Panobacumab | 885053-97-4 | Details |
| Tremelimumab | 745013-59-6 | Details |
| Ibalizumab | 680188-33-4 | Details |
| Epitumomab | 372075-37-1 | Details |
| Besilesomab | 537694-98-7 | Details |
| Pagibaximab | 595566-61-3 | Details |
| Raxibacumab | 565451-13-0 | Details |
| Yttrium (90Y) Tacatuzumab Tetraxetan | 476413-07-7 | Details |
| Denosumab | C6404H9912N1724O2004S50 | 615258-40-7 | Details |
| Bapineuzumab | 648895-38-9 | Details |
| notuzumab | 635715-01-4 | Details |
| Volociximab | 558480-40-3 | Details |
| Iratumumab | 640735-09-7 | Details |
| Tucotuzumab Celmoleukin | 339986-90-2 | Details |
| Teneliximab | 395639-53-9 | Details |
| Urtoxazumab | 502496-16-4 | Details |
| Elsilimomab | 468715-71-1 | Details |
| Exbivirumab | 569658-80-6 | Details |
| Belimumab | 356547-88-1 | Details |
| Research Grade Sibrotuzumab | Details |
| Research Grade Taplitumomab | Details |
| Vapaliximab | 336801-86-6 | Details |
| Erlizumab | 211323-03-4 | Details |
| reslizumab | 241473-69-8 | Details |
| Ecromeximab | 292819-64-8 | Details |
| Pritumumab | 499212-74-7 | Details |
| Tefibazumab | 521079-87-8 | Details |
| Libivirumab | 569658-79-3 | Details |
| Lemalesomab | 250242-54-7 | Details |
| Research Grade Bivatuzumab | Details |
| Research Grade Pintumomab | Details |
| Cixutumumab | 947687-12-9 | Details |
| Farletuzuma | 896723-44-7 | Details |
| SU5408 | C18H18N2O3 | 15966-93-5 | Details |
| Robatumumab | 934235-44-6 | Details |
| Elotuzumab | 915296-00-3 | Details |
| Research Grade Anatumomab | Details |
| Figitumumab | 943453-46-1 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 | ||||